February 7, 2026 - ChartAlert®

BLUESTARCO – Q3 FY26 Earnings Call – 30-Jan-26

BLUESTARCO’s topline growth hinges on summer demand and EMP order revival, while bottomline resilience depends on price hike execution and cost controls; margins face structural pressure from wage codes and commodity volatility, but selective capital allocation and B2B diversification provide downside buffers.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Average summer, EMP order book stabilizes (8–10% CAGR), price hikes partially successful (5–7% net realization).
Outcome: Revenue grows 8–10% YoY in FY27; UCP margins hold at 8.5%, EMP margins at 6.5–7%. EPS grows 5–8% YoY, supported by cost controls and selective project execution. ROCE remains 25%+. Exports contribute 5–7% of revenue by FY29, trailing the 15% target.

VOLTAS – Q3 FY26 Earnings Call – 29-Jan-26

VOLTAS’ topline resilience hinges on RAC seasonality and Volbek scale-up, while bottomline recovery depends on commodity pass-through and project execution; margins face structural pressure unless cost optimization outpaces input inflation.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Normal summer demand, commodity prices stabilize, BEE price hikes absorbed (elasticity <5%), data center orders materialize.
Outcome: RAC revenue grows 3–5% YoY; market share holds at 17–18%. Voltbek break-even by Q4 FY27 (8–10% market share). Project revenue flattish but margins improve to 9–10% on MEP mix. EPS stable; margins 7–8%.

GVT&D – Q3 FY26 Earnings Call – 28-Jan-26

GE Vernova T&D India’s structural tailwinds (500GW renewables, TBCB adoption) and disciplined execution support 18–22% topline growth and 25–27% EBITDA, but HVDC timing, China policy, and export volatility introduce 10–15% downside risk to revenue and 100–200bps margin compression in adverse scenarios.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Adani Khavda booked in 1H FY27, Barmer-South Kalamb finalized by Q2 FY27, and TBCB pipeline supports 18–22% revenue growth. EBITDA sustains at 25–27% on execution leverage and pricing discipline. Export contributes 20–25% of revenue. Implication: In-line with guidance; cash flow funds capex.

VEDL – Q3 FY26 Earnings Call – 29-Jan-26

VEDL’s topline resilience (volume-led) and margin expansion (cost leadership) are structurally supported, but execution risks (project delays, commodity volatility) and balance sheet leverage (VRL maturities) introduce asymmetric downside—monitor ASP commissioning and BALCO ramp-up as near-term catalysts.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: ASP commissioning (Q1 FY27), aluminum LME at $2,700/ton, and BALCO ramp-up on schedule.
Outcome: EBITDA hits $6.1–6.3B; aluminum/power drive 40%+ margins. Deleveraging accelerates (0.9x net debt/EBITDA); 10–12GW power expansion secures PPAs. Zinc International costs stabilize at $1,150/ton; HZL OFS proceeds (₹3,000 crore) reduce VRL debt by $300M.

CIPLA – Q3 FY26 Earnings Call – 23-Jan-26

Cipla’s topline resilience hinges on US pipeline execution (respiratory/peptides) and India chronic therapy growth, while margins face near-term pressure from R&D lumpiness and Lanreotide disruption; FY27 EBITDA recovery to 21%+ requires flawless launch sequencing and cost normalization.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Lanreotide resumes in H1 FY27; two respiratory launches in H1 FY27 (one sole generic).
Generic Victoza and one peptide launch in FY27; Yurpeak traction sustains (~₹150 crore/month).
Result: US revenue stabilizes at $130–150M/quarter; EBITDA margin recovers to 20–21%; FY27 guidance maintained at 21%.

BAJAJ-AUTO – Q3 FY26 Earnings Call – 30-Jan-26

Bajaj Auto’s Base case sees contained inflation, steady domestic growth, and KTM recovery driving 15–18% revenue with 20–21% margins. Bear case risks commodity shocks, rupee appreciation, and demand slowdown, trimming margins to 19%. Bull case highlights premiumization, EV adoption, and KTM synergies, boosting revenue 20%+.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Trigger: Commodity inflation contained (50–60bps drag), 12–15% domestic growth sustains, export diversification offsets dislocations, KTM turnaround on track.
Outcome: Revenue +15–18%, EBITDA margin 20–21%, PAT +15%; EV contributes 30% of domestic revenue by FY27; BACL RoE sustains at 20%+.